BIOCEPT, INC. Lessee, Operating Lease, Liability, to be Paid, Year Four
BIOCEPT, INC. had Lessee, Operating Lease, Liability, to be Paid, Year Four of $1.80 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour · last filed 2023-08-14
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $1.80M.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $1.80M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Four $1.76M.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Four $1.76M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Four |
|---|---|
| 2023-06-30 | $1.80M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.80M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $1.76M 10-K · filed 2023-04-17 |
| 2022-09-30 | $1.76M 10-Q/A · filed 2023-04-17 |
| 2022-06-30 | $1.76M 10-Q · filed 2022-11-10 |
| 2022-03-31 | $1.76M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $1.72M 10-K · filed 2022-04-05 |
| 2020-12-31 | $1.67M 10-K · filed 2021-03-31 |